FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileNEXGEL, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
NXGLW
NEXGEL, Inc. Stock AnalysisComprehensive stock analysis for NEXGEL, Inc. (NXGLW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisNXGLW
NXGLW
NEXGEL, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
NXGLW
  1. Home
  2. Stocks
  3. NEXGEL, Inc.

NEXGEL, Inc.

🇺🇸NXGLW•NASDAQ

NEXGEL, Inc.

🇺🇸NXGLW•NASDAQ
Market cap
$550.56K

Your view on NXGLW

Mkt Cap
$550.56K
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About NEXGEL, Inc.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Adam R. Levy
Headquarters
2150 Cabot Boulevard West, Langhorne, PA, US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Adam R. Levy
Headquarters
2150 Cabot Boulevard West, Langhorne, PA, US
Description

NEXGEL, Inc. is a company that manufactures specialized hydrogels and gels, notable for their high water content, electron beam cross-linking, and aqueous polymer base.

These advanced materials are widely utilized across several sectors, including wound care, medical diagnostics, transdermal drug delivery systems, and various cosmetic applications.

Their diverse product portfolio features items such as facial masks, under-eye patches, blister-shielding foot care, hexagel, cracked heel repair patches, and cooling fever patches. Originally known as AquaMed Technologies, Inc., the company officially adopted the name NEXGEL, Inc. in November 2019.

Founded in 1997, its operations are headquartered in Langhorne, Pennsylvania.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for NEXGEL, Inc.. Starting points for NEXGEL, Inc.: EPS -$13.63, beta 0.77 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for NEXGEL, Inc.. Trailing twelve-month EPS for NEXGEL, Inc. stands at -$13.63. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for NEXGEL, Inc.. NEXGEL, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold NXGLW12 companies
More Medical - Instruments & Supplies companies
TickerTypeCompanySectorExchangeMkt cap
SMTISanara MedTech Inc.HealthcareNASDAQ$298.9M
SOAGYSartorius AGHealthcareOTC$82.3B
SOLVSolventum CorporationHealthcareNYSE$14.4B
SRTOYSartorius Stedim Biotech S.A.HealthcareOTC$209.8B
SSSGYSartorius AGHealthcareOTC$15.8B
STAASTAAR Surgical CompanyHealthcareNASDAQ$1.2B
STSSSharps Technology, Inc.HealthcareNASDAQ$53.7M
STVNStevanato Group S.p.A.HealthcareNYSE$4.3B
STXSStereotaxis, Inc.HealthcareAMEX$95.0M
SUVPFSartorius AGHealthcareOTC$18.7B
SVSOSheerVision, Inc.HealthcareOTC$2,551
TCGGYTecan Group AGHealthcareOTC$2.3B
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold NEXGEL, Inc., and how their positions are changing. At a $550,561 market value, institutional positions materially move NEXGEL, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by NEXGEL, Inc. executives and directors. Shares of NEXGEL, Inc. have traded between $0.01 and $0.31 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for NEXGEL, Inc.. Coverage tracks NEXGEL, Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of NEXGEL, Inc.

NXGLW AnalysisFair
Past
1
Growth
5
Health
3
Profit
1
Value
1